016790 — CanariaBio Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeSmall Cap

Annual balance sheet for CanariaBio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,036	14,069	5,394	6,907	12,084
Net Total Accounts Receivable
Net Total Receivables	55,001	49,021	43,349	57,298	35,958
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	74,904	75,671	66,186	91,026	66,550
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,062	18,835	25,946	30,039	30,720
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	97,377	98,205	93,774	271,272	123,385
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	34,131	35,066	29,790	144,724	173,158
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	37,922	39,237	36,146	228,900	176,793
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	59,456	58,968	57,628	42,371	-53,408
Total Liabilities & Shareholders' Equity	97,377	98,205	93,774	271,272	123,385
Total Common Shares Outstanding